| Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer (NCT03153280) | Cancer Trials Ireland | 2022-01-13 |
| A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies (NCT04937166) | Kahr Medical | 2022-01-13 |
| DDI Study of Evobrutinib and Carbamazepine (NCT05248945) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2022-01-13 |
| RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients. (NCT04963413) | University of Florida | 2022-01-13 |
| Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19 (NCT04844268) | SENAI CIMATEC | 2022-01-13 |
| Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy Subjects (NCT05241535) | Tanabe Pharma America, Inc. | 2022-01-12 |
| RTX-224 Monotherapy in Patients With Solid Tumors (NCT05219578) | Rubius Therapeutics | 2022-01-12 |
| A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer (NCT05504213) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2022-01-12 |
| Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects (NCT05226923) | Sumitovant Biopharma, Inc. | 2022-01-12 |
| A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors (NCT05194072) | Seagen, a wholly owned subsidiary of Pfizer | 2022-01-12 |
| Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation (NCT05282459) | Tian Yi Zhang | 2022-01-12 |
| Evaluate the Safety and Pharmacokinetics of Ricolinostat (NCT05193851) | Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. | 2022-01-12 |
| A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies (NCT05081609) | Ascendis Pharma Oncology Division A/S | 2022-01-11 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects (NCT05677035) | Hyundai Pharm | 2022-01-11 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Healthy Participants (NCT05105607) | Ashvattha Therapeutics, Inc. | 2022-01-11 |
| To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement. (NCT05196295) | HoHo Biotech | 2022-01-11 |
| Pharmacokinetics of SP-104 (NCT05002946) | Scilex Pharmaceuticals, Inc. | 2022-01-11 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus (NCT05155345) | Hoffmann-La Roche | 2022-01-11 |
| Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult Participants (NCT05202145) | Alexion Pharmaceuticals, Inc. | 2022-01-11 |
| Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets (NCT05168683) | Allena Pharmaceuticals | 2022-01-11 |
| Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CHI-915 in Healthy Participants (NCT05210634) | Canopy Growth Corporation | 2022-01-11 |
| Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer. (NCT05181462) | Cantargia AB | 2022-01-11 |
| A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastatin in Healthy Participants (NCT05176314) | Loxo Oncology, Inc. | 2022-01-11 |
| rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG (NCT04943848) | Ann & Robert H Lurie Children's Hospital of Chicago | 2022-01-10 |
| Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers (NCT05245669) | Enzene Biosciences Ltd. | 2022-01-10 |
| Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers (NCT05245838) | Dynavax Technologies Corporation | 2022-01-10 |
| Evaluation of Metastatic Disease and Oncological Treatment in Patients With Colon Cancer Using Zebra Fish Avatars (NCT06270017) | University Hospital, Linkoeping | 2022-01-10 |
| The Safety of STSA-1002 Following Intravenous Infusion in Healthy Subjects (NCT05166837) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2022-01-10 |
| Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers (NCT05121766) | Hackensack Meridian Health | 2022-01-10 |
| A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer (NCT05130060) | Mayo Clinic | 2022-01-10 |
| Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers (NCT06508645) | Daewoong Pharmaceutical Co. LTD. | 2022-01-10 |
| ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization (NCT05198063) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2022-01-10 |
| Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985 (NCT04983238) | Byondis B.V. | 2022-01-10 |
| A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects (NCT05178901) | Public Health Vaccines LLC | 2022-01-10 |
| BE of Euthyrox® Tablets (Merck Nantong Versus Merck Darmstadt Sites) (NCT05174000) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2022-01-10 |
| A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2 (NCT05113862) | Gylden Pharma Ltd | 2022-01-10 |
| CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM) (NCT04990427) | Lisata Therapeutics, Inc. | 2022-01-10 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of TB001 in Healthy Subjects (NCT05308940) | Shenzhen Turier Biotech Co., Ltd | 2022-01-10 |
| To Evaluate the Safety, Tolerability, and Pharmacokinetics of YG1699（Antidiabetic） in Healthy Chinese Sbjects (NCT05089617) | Youngene Therapeutics Inc., Ltd. | 2022-01-09 |
| A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults (NCT05903118) | Argorna Pharmaceuticals Co., LTD | 2022-01-08 |
| A Study to Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid Tumors (NCT05114915) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-01-07 |
| A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects (NCT05171348) | Keymed Biosciences Co.Ltd | 2022-01-07 |
| Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens (NCT05216510) | Tonix Pharmaceuticals, Inc. | 2022-01-07 |
| A Study of TAK-951 in Healthy Adults (NCT06610279) | Takeda | 2022-01-07 |
| Pharmacokinetics of Progesterone in Pregnancy-2 (NCT04753957) | Thomas Jefferson University | 2022-01-07 |
| A Phase I Pharmacokinetics Study for KT07 Capsule (NCT05223660) | Yiling Pharmaceutical Inc. | 2022-01-07 |
| COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers (NCT05181683) | Regeneron Pharmaceuticals | 2022-01-07 |
| Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors (NCT05228015) | Ikena Oncology | 2022-01-07 |
| Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma (NCT05227144) | ORIC Pharmaceuticals | 2022-01-06 |
| A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors (NCT05170958) | Nanjing Leads Biolabs Co.,Ltd | 2022-01-06 |
| Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial (NCT05377619) | Universidade de Passo Fundo | 2022-01-06 |
| A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors (NCT04893759) | Ascentage Pharma Group Inc. | 2022-01-06 |
| Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults (NCT05152901) | De Motu Cordis | 2022-01-06 |
| A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19 (NCT05162365) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-01-06 |
| Study for Treatment of Chronic Diabetic Foot Ulcers With the Investigational Allogeneic Cell Therapy Product, hOMSC200 (NCT06003530) | Cytora Ltd. | 2022-01-06 |
| MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis (NCT07182864) | Minghui Pharmaceutical (Hangzhou) Ltd | 2022-01-06 |
| A Study Investigating Lu AG06466 in Healthy Men (NCT05201092) | H. Lundbeck A/S | 2022-01-05 |
| Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants (NCT05205447) | Eli Lilly and Company | 2022-01-05 |
| Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases (NCT05081921) | Jagiellonian University | 2022-01-05 |
| A Study of TAK-103 in Adult With Solid Tumors (NCT05164666) | Takeda | 2022-01-05 |
| A Study of HS-20089 in Patients With Advanced Solid Tumors (NCT05263479) | Shanghai Hansoh Biomedical Co., Ltd | 2022-01-05 |
| The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting. (NCT05010200) | Ashutosh Kumar Tewari | 2022-01-05 |
| Lenvatinib With Taxane Drugs Treatment for Advanced Gastric Cancer (NCT05171530) | Ruijin Hospital | 2022-01-05 |
| HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors (NCT04965220) | Shanghai Henlius Biotech | 2022-01-05 |
| A Study to Evaluate the Safety and Pharmacokinetics of AD-221 Compared to Coadministration of AD-221A and AD-221B (NCT05202405) | Addpharma Inc. | 2022-01-05 |
| A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors (NCT05110807) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-01-05 |
| A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT05140811) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2022-01-05 |
| Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin Model (NCT05181852) | Initiator Pharma | 2022-01-05 |
| Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC (NCT05430386) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2022-01-05 |
| Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy (NCT05443178) | University of Zurich | 2022-01-04 |
| A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1) (NCT05118789) | Nuvalent Inc. | 2022-01-04 |
| Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/Recurrent Advanced Solid Tumors (NCT05430360) | Grit Biotechnology | 2022-01-04 |
| HMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NCT05190068) | Hutchmed | 2022-01-04 |
| ADME Study of [14C]-Jaktinib in Healthy Male Subjects (NCT05150717) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2022-01-04 |
| NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa (NCT05083260) | BioVie Inc. | 2022-01-04 |
| A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers (NCT05192369) | Concert Pharmaceuticals | 2022-01-04 |
| A Study to Assess S-309309 in Healthy and Obese Participants (NCT05247970) | Shionogi | 2022-01-04 |
| Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women (NCT04283656) | Thomas Jefferson University | 2022-01-04 |
| A Study to Evaluate the Effect of Itraconazole on Pharmacokinetics (PK) of SHR8554 in Healthy Adult Subjects (NCT05928988) | Jiangsu HengRui Medicine Co., Ltd. | 2022-01-04 |
| To Evaluate the Safety, Pharmacokinetic and the Effect of Food After Administration of ABN401 in Healthy Adult Volunteers (NCT05248074) | Abion Inc | 2022-01-04 |
| A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors (NCT05114759) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-01-04 |
| A Study to Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy Participants (NCT05053165) | LISCure Biosciences | 2022-01-04 |
| Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic Foot Ulcers (NCT05165628) | Cynata Therapeutics Limited | 2022-01-04 |
| A Study of Oncolytic Virus Injection (RT-01) in Combination With PD-1 Inhibitor in Patients With Advanced Solid Tumors (NCT05228119) | The Affiliated Hospital of Xuzhou Medical University | 2022-01-04 |
| Metoclopramide Versus Hyoscine Butylbromide in Shortening Duration of First Stage of Labour (NCT05222646) | Uwakwe Emmanuel Chijioke | 2022-01-03 |
| NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma (NCT04930783) | Dana-Farber Cancer Institute | 2022-01-03 |
| Dose-finding Study for AdimrSC-2f Vaccine (NCT05104489) | Adimmune Corporation | 2022-01-03 |
| Clonidine Versus Tranexamic Acid in Reduction of Blood Loss (NCT05371574) | Uwakwe Emmanuel Chijioke | 2022-01-03 |
| Lidocaine Infusion for Propofol Dose Reduction in ERCP Procedure (NCT05274984) | Iuliu Hatieganu University of Medicine and Pharmacy | 2022-01-03 |
| AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study (NCT05184868) | Arecor Limited | 2022-01-03 |
| Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol (NCT05094609) | McMaster University | 2022-01-03 |
| Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy (NCT05070351) | Duke University | 2022-01-03 |
| Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease (NCT04858074) | University of Ibadan | 2022-01-03 |
| Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics (NCT05490888) | PharmaIN | 2022-01-03 |
| An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms (NCT05123365) | University of California, Irvine | 2022-01-03 |
| A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) (NCT05160168) | Theseus Pharmaceuticals | 2022-01-03 |
| PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study (NCT05222087) | Peter MacCallum Cancer Centre, Australia | 2022-01-03 |
| CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed (NCT05162976) | City of Hope Medical Center | 2022-01-03 |
| Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics. (NCT04767776) | Centre Hospitalier Universitaire de Saint Etienne | 2022-01-03 |
| Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors (NCT05118841) | Nanjing Zenshine Pharmaceuticals | 2022-01-03 |